Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Park Medi World to acquire Medicity Hospital in Rudrapur, enter Uttarakhand
Hospital chain Park Medi World Limited is acquiring The Medicity Hospital in Rudrapur. The deal is valued at Rs 177 crore and is an all-cash transaction. This acquisition marks Park Group's entry into Uttarakhand. The Medicity Hospital is a multi-super speciality facility with 330 beds. This move aligns with the company's growth strategy to expand its network in underserved markets.
Venus Remedies gets Saudi FDA approval for speciality oncology therapy
Venus Remedies Limited has secured its first global marketing authorization for its specialty oncology therapy, Plerixafor, from the Saudi Food and Drug Authority (SFDA). This hematopoietic stem cell mobilizer is crucial for patients undergoing stem cell transplantation for multiple myeloma and non-Hodgkin lymphoma.

1080% returns in five years! Multibagger stock rises despite cautious trends on Dalal Street
Himadri Speciality Chemical shares gained nearly 2% to ₹590 after announcing an investment in Sicona Battery Technologies. The company has invested AUD 25.59 lakh in additional Compulsorily Convertible Notes, raising its total to 1.67 crore CCNs, while maintaining no additional voting rights.
Sun Pharma Q4 Preview: Can Unloxcyt and speciality drugs help pharma major deliver another strong quarter?
Sun Pharma is expected to post double-digit revenue growth in Q4FY26, driven by strong performance across speciality drugs, domestic formulations, and emerging markets. Brokerages highlight US portfolio strength, new launches like Unloxcyt, and a steady margin outlook despite higher R&D spending, with EBITDA growth supported by diversified global business momentum outlook
Why PSU banks look stronger than private lenders right now: PL Capital’s Amisha Vora explains
Amisha Vora, Chairperson & MD, PL Capital, believes PSU banks look more attractive than private banks due to their stronger ability to raise low-cost deposits. She is positioning portfolios toward exporters, metals, defence and power-linked sectors amid sharp rupee depreciation. Vora also sees opportunities in niche auto ancillaries, speciality pharma and engineering exporters, while remaining cautious on IT and broader consumer durable plays due to weak growth visibility and rising competition.

Alembic Pharma bets on branded drugs in the US
While the company hopes to push into branded speciality drugs, which offer a better value proposition in the US, its core generics business will continue to remain a priority
Speciality Restaurants consolidated net profit rises 38.91% in the March 2026 quarter
Sales rise 13.02% to Rs 116.42 crore
DMCC Speciality Chemicals consolidated net profit rises 18.24% in the March 2026 quarter
Sales rise 41.86% to Rs 177.64 crore
LANXESS inks pact with HPCL to sell aviation, industrial lubricants in India, SAARC region
Speciality chemicals firm LANXESS has signed an agreement with Hindustan Petroleum Corporation Limited HPCL to market aviation and industrial lubricants in India and the SAARC region. The partnership aims to provide advanced lubricant solutions.

Park Medi World Q4 Results: Stock gives up initial spurt despite revenue growth, margin expansion
The group now consolidates 22 subsidiaries, spanning hospital brands including Aggarwal Hospital, Blue Heavens Healthcare, Park Medicity, Kailash Super-Speciality, and Umkal Healthcare, among others.
Privi Speciality Chemicals consolidated net profit rises 40.86% in the March 2026 quarter
Sales rise 17.60% to Rs 721.52 crore

Shyam Metalics Q4 Results: Profit rises 46%; board clears ₹2,700 crore capex
Shyam Metalics and Energy reported strong Q4 earnings growth with higher margins and announced a ₹2,700 crore expansion plan aimed at boosting speciality steel and stainless steel capacities.